Allecra Therapeutics - Articles and news items

Allecra Therapeutics closes €22 Million Series B financing round

Industry news / 15 June 2016 / Victoria White, Digital Content Producer

The proceeds will fund Phase II development of AAI202 – a novel antibiotic combination designed to treat drug-resistant Gram-negative bacterial infections…

 

The deadline for submissions to the EPR Awards is 9 June 2017! Entry is FREE, so don't delay...
+